Autologous Mesenchymal Stromal Cells for Multiple Sclerosis

Clinical trial NCT02495766 · COMPLETED

Trial details

NCT number: NCT02495766
Sponsor: Banc de Sang i Teixits
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis

Start date: 2015-05-11
Primary completion: 2017-11-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.